YEM-68937-63089
5 vaccinations
6 coded responses
34 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 021 / MA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-06
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Dyspnoea, Unevaluable event — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Shortness of breath and dizziness · Healthcare visit (other): Covid test scheduled for tomorrow at employee healthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain, Dyspnoea — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Severe shortness of breath and chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-21
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
-
2021-03-04
Call successfulParticipant prefers to complete VAERS report online
-
2021-04-13
Survey response — 3 months, dose 2MedDRA: Invasive ductal breast carcinoma — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have been diagnosed with invasive ductal carcinoma of the breast. I am otherwise healthy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-17
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-16
Survey response — day 14, dose 3MedDRA: Emergency care, Vertigo, Vertigo positional, Vestibular neuronitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: I had a severe episode of vertigo on Friday 10/8/21. I went to the ER and was diagnosed with benign paroxysmal positional vertigo, presumed to be from vestibular neuritis. · Healthcare visit (other): I had a head MRI which was negative. I was given a dose of meclizine and discharged home.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Report sent to call center — day 14, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2021-10-18
-
2021-10-18
Call successfulParticipant prefers to complete VAERS report online
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2022-01-01
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: I got Covid in January 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-06-10
Dose 4 — Pfizer-BioNTech
- 2022-10-01
-
2022-12-03
Dose 5 — Moderna
- 2022-12-11
- 2022-12-11
- 2022-12-19
- 2022-12-24
- 2023-01-02
- 2023-01-07
-
2023-01-16
Survey response — day 42, dose 5MedDRA: Cough, Oropharyngeal pain, Pain, Pyrexia — Feeling: Poor · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-03-04
- 2023-06-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-06-10 | Pfizer-BioNTech | No |
| 5 | 2022-12-03 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | Successful | Participant prefers to complete VAERS report online |
| 2021-01-14 | Successful 2021-03-04 |
Participant prefers to complete VAERS report online |
| 2021-04-13 | Successful 2021-06-17 |
Reported to VAERS voluntarily prior to GDIT contact |
| 2021-10-16 | Successful 2021-10-18 |
Participant prefers to complete VAERS report online |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath and dizziness
Healthcare visit (other): Covid test scheduled for tomorrow at employee health
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Severe shortness of breath and chest pain
Release 7 — 3 months, dose 2
Symptoms: I have been diagnosed with invasive ductal carcinoma of the breast. I am otherwise healthy.
Release 10 — day 14, dose 3
Symptoms: I had a severe episode of vertigo on Friday 10/8/21. I went to the ER and was diagnosed with benign paroxysmal positional vertigo, presumed to be from vestibular neuritis.
Healthcare visit (other): I had a head MRI which was negative. I was given a dose of meclizine and discharged home.
Release 11 — 6 months, dose 3
Symptoms: I got Covid in January 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | · | · | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Invasive ductal breast carcinoma | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SD | Vertigo positional | · | · | ✓ |
| SD | Vestibular neuronitis | · | · | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release